Skip to main content

 CUTTING EDGE TECHNOLOGY TO BIOPRINT MINI-KIDNEYS! 


Using 3D bioprinting technology, the researchers produced miniature human kidneys in the lab. The study includes biotech company Organovo, Murdoch Children's Research Institute (MCRI).

The research team also validated the use of 3D bioprinted human mini-kidneys to screen for drug toxicity from a class of drugs known to cause kidney damage in humans. The study demonstrated how 3-D bioprinting of stem cells would produce sheets of kidney tissue large enough for transplants.

Artificial living tissue was produced using extrusion-based 3D bioprinting technology and bioink consisting of stem cells.

Melissa Little, who started growing kidney organoids in 2015, stated that the 3D bioprinting method allows a faster and more reliable process. The study found that with 3D bioprinting, it was able to create about 200 mini-kidneys in 10 minutes without sacrificing quality.

The mini-kidneys produced resemble a normal-sized kidney. Using mini-organs, drugs will be screened to find new treatments for kidney disease. It will also be tested whether a new drug is likely to damage the kidney. The toxicity of aminoglycosides, a class of kidney-damaging antibiotics, was also tested in this study. Professor Little stated that they found that the death of certain cell types increased in kidneys treated with aminoglycosides.


Credit : https://www.technologynetworks.com/cell-science/news/3d-bioprinting-improves-kidney-organoid-generation-343142


REFERENCES

Cutting edge technology to bioprint mini-kidneys

Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation

Kynan T. Lawlor

Jessica M. Vanslambrouck

J. William Higgins

Alison Chambon

Kristina Bishard

Pei Xuan Er

Sean B. Wilson

Sara E. Howden

Ker Sin Tan

Fanyi Li

Lorna J. Hale

 Derek Arndt

Benjamin Shepherd

 Stephen Pentoney

Sharon C. Presnell

Alice E. Chen









Comments

Post a Comment

Popular posts from this blog

NOSE CARTRIDGE PRINTED WITH 3D BIOPRINTING TECHNOLOGY! A team of University of Alberta researchers has produced a specially shaped cartilage u sing three-dimensional bioprinting technology  that can be used in surgical applications. The hydrogel prepared with cells taken from the patient was used in bioprinting. Surgeons reshape the cartilage taken from the patient's ribs to fit the size and shape required for reconstructive surgery and transplant the patient. With this traditional procedure, however, there is a risk of complications in the patient. The other problem is that the rib compartment that protects the lungs needs to be opened to reconstruct the nose. This region has a vital anatomical importance. The patient's lungs may have collapsed. Researchers say that this study is an example of regenerative medicine. The cartilage, which is specially printed for the patient and grown in the laboratory, has the potential to eliminate the risk of collapse in the lungs, infection ...
Post a Comment
Read more
3D BIOPRINTING TECHNIQUE CONTROLS CELL ORIENTATION!  Using 3D bioprinting technology, tissue scaffolds that mimic tissues can be printed. Controlling cellular organization in these scaffolds designed for tissue engineering studies is a complex and challenging process. Produced cellular scaffolds must perform like natural tissues. To achieve this, cells must have a regular structure in terms of spatial distribution and alignment. In this study, cellular orientation was controlled by the technique developed for fast, simple and cost-effective printing of multi-compartment hydrogel fibers. Alginate and GELMA hydrogel fibers were printed in the determined pattern with the static mixer integrated into the coaxial microfluidic system. In the engineered microstructure, GelMA chambers provide a suitable environment for the cell, while alginate chambers offer morphological and mechanical properties that guide cellular orientation. It has been demonstrated in this study that cellular alignme...
Post a Comment
Read more
PORCINE HEART TRANSPLANTATION TO ADULT HUMAN WITH END STAGE HEART DISEASE! The patient accepted a pig heart transplant, which was his only option for survival. In the first of its kind surgery, 57-year-old David Bennett successfully transplanted a genetically modified (GM) pig heart. The patient was found to be in good condition 3 days after the operation. The historic operation was performed at the University of Maryland School of Medicine (UMSOM) in the USA. This transplant showed that a genetically modified animal heart can function like a human heart without being rejected by the body. The day before the surgery, patient David Bennett told himself, “Die or get this transplant. I want to live. I know this is shooting a bullet into the dark. But this is my last choice,” he said, and accepted the heart from the pig. The U.S. Food and Drug Administration (FDA) has granted emergency clearance for surgery on New Year's Eve through its expanded access provision. An experimental medic...
Post a Comment
Read more